Avidity, Affinity, and B7H3 as a Cancer Cell Marker
Successful targeting of cell-surface tumor markers by various methods has made identification of such molecules a potentially high pay-off goal for the creation of new [...]
Genomic Insights into Cancer from the 100,000 Genomes Cancer Program
The 100,000 Genomes Cancer Program is a UK government research initiative aimed at integrating genomic data with clinical information to gain insights into the molecular [...]
Live on our YouTube our Latest Webinar: Combining Synthetic and Evolutionary Biology Reveals DNA Therapy to Combat Cancer Chemoresistance
https://www.youtube.com/watch?v=ACj85aO00hY&t=176s
Natural Killer T (NKT) Cells in Cancer Immunotherapy
While T cells engineered with chimeric antigen receptors (CAR-T cells) have revolutionized the landscape of hematologic malignancy treatment, their efficacy against solid tumors remains limited. [...]
KromaTiD Webinar | Combining Synthetic and Evolutionary Biology Reveals DNA Therapy to Combat Cancer Chemoresistance
Register below for the KromaTiD Webinar | Combining Synthetic and Evolutionary Biology Reveals DNA Therapy to Combat Cancer Chemoresistance Drug resistance is still an ongoing [...]
Telomere Length Measurement via Q-FISH
DNA damage is occurring within our cells constantly. Like a boat that is springing new leaks all the time, repair must also be ongoing or [...]
Machine Learning Model Uses Gut Microbiome as a Predictor of CAR-T Patient Outcomes
CAR-T cells, or chimeric antigen receptor T cells, hold great potential for the treatment of cancer and other diseases. Although several CAR-T therapies have received [...]
KromaTiD’s Dark Lab Files: The Great Race to Cure Cancer – CAR-T Segment
As technologies evolve, therapies for cancer have advanced and more and more researchers are finding out how the science of our bodies make us ill [...]